Company Filing History:
Years Active: 2006
Title: The Innovations of Mats Kihlén
Introduction
Mats Kihlén is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biotechnology, particularly in the area of matrix metalloproteinases. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Mats Kihlén holds a patent for a novel invention titled "Matrix metalloproteinase polypeptide." This patent provides genes encoding novel matrix metalloproteinases termed MMP. It includes constructs and recombinant host cells incorporating the genes, the MMP polypeptides encoded by the genes, antibodies to the MMP polypeptides, and methods of making and using all of the foregoing. This invention represents a significant advancement in the understanding and application of matrix metalloproteinases.
Career Highlights
Kihlén is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development projects that aim to improve health outcomes. His expertise in biotechnology and patenting has positioned him as a valuable asset in the industry.
Collaborations
Mats Kihlén has collaborated with notable colleagues such as Timothy Wood and Jonas Ekblom. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared research goals.
Conclusion
Mats Kihlén's contributions to the field of biotechnology through his patent on matrix metalloproteinases highlight the critical role of inventors in advancing medical science. His work at Pfizer Corporation and collaborations with esteemed colleagues further emphasize the importance of teamwork in driving innovation.